GRK2 and GRK5—The 2 critical kinases in cardiac pathophysiology
Why the study?
GRK2 and GRK5 are upregulated in heart failure across cardiac cell types, requiring examination of their cell-specific roles and therapeutic targeting.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
GRK2/GRK5 upregulation in HF may identify novel targets; leaves open cell-specific contributions in human disease.
Structured PICO
P
Population
Heart failure (human and mouse models)
I
Intervention
GRK2 and GRK5 inhibitors (e.g., paroxetine)
GRK2 and GRK5 play a central role in heart failure pathophysiology across multiple cardiac cell types, and their targeted inhibition represents a potential new therapeutic strategy.
Cite This Study
Roy et al. (2025) studied this question.